Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 55463-0005
Start Marketing Date : 2003-11-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Goserelin acetate (JAN/USP) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Goserelin acetate (JAN/USP), including repackagers and relabelers. The FDA regulates Goserelin acetate (JAN/USP) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Goserelin acetate (JAN/USP) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Goserelin acetate (JAN/USP) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Goserelin acetate (JAN/USP) supplier is an individual or a company that provides Goserelin acetate (JAN/USP) active pharmaceutical ingredient (API) or Goserelin acetate (JAN/USP) finished formulations upon request. The Goserelin acetate (JAN/USP) suppliers may include Goserelin acetate (JAN/USP) API manufacturers, exporters, distributors and traders.
click here to find a list of Goserelin acetate (JAN/USP) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Goserelin acetate (JAN/USP) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Goserelin acetate (JAN/USP) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Goserelin acetate (JAN/USP) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Goserelin acetate (JAN/USP) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Goserelin acetate (JAN/USP) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Goserelin acetate (JAN/USP) suppliers with NDC on PharmaCompass.
We have 1 companies offering Goserelin acetate (JAN/USP)
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
